Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.17051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Weronika Świtlik und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland; weronika_switlik@sggw.edu.pl. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Cell Proliferation, Gene Expression Regulation, Neoplastic, Lung Neoplasms.
Abstract (Originalsprache)
BACKGROUND/AIM: Non-small cell lung cancer (NSCLC) is the deadliest form of cancer worldwide. Understanding the mechanisms of lung cancer development is vital for targeted therapy advancements. This article explores the little-known role of the guanylate kinase-associated protein (GKAP), encoded by the Disks large-associated protein 1 (DLGAP1) gene, in NSCLC along with assessing microRNA-30a-5p's influence on DLGAP1 gene expression in the A549 cell line. MATERIALS AND METHODS: Experiments were conducted on A549 cells transfected with synthetic oligonucleotides. The luciferase assay was employed to confirm the binding site of miR-30a-5p to the 3'UTR of DLGAP1 mRNA. The role of miRNA-30a-5p mimic in regulating potential target gene expression at the protein and mRNA levels was studied by performing RT-qPCR and western blot analyses. The effects of DLGAP1 knockdown and miRNA-30a-5p mimic on cell viability and the cell cycle were evaluated using the MTT test and flow cytometry with annexin/iodide cell staining. RESULTS: The luciferase assay indicated that miR-30a-5p has the ability to bind to the 3'UTR of DLGAP1 mRNA. RT-qPCR revealed that the overexpression of miR-30a-5p down-regulates DLGAP1 mRNA. Western blot analysis indicated that miR-30a-5p slightly reduces the level of the GKAP protein. Knockdown of DLGAP1 with synthetic oligonucleotides, as well as transfection with a miR-30a-5p mimic, significantly attenuates cell proliferation and increases the number of cells in the early and late stages of apoptosis. CONCLUSION: Our findings reveal the antiproliferative effect of miR-30a-5p and DLGAP1 gene knockdown on A549 cancer cells, implying that these elements could be considered as therapeutic targets for personalized medicine in NSCLC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland; weronika_switlik@sggw.edu.pl.
- Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland.
- Institute of Biological Sciences, Cardinal Stefan Wyszyński University in Warsaw, Warsaw, Poland.
- Division of Immunology, Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences-SGGW, Warsaw, Poland.
- Department of Biochemistry and Microbiology, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland.
- Department of Physics and Biophysics, Institute of Biology, Warsaw University of Life Sciences, Warsaw, Poland.
Zitieren
APA
Świtlik, W., Wyżewski, Z., Gregorczyk-Zboroch, K., Gietler, M., Pudlarz, A., Szewińska, J., Orzechowski, S., Jakieła, S., & Szemraj, J. (2024). Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17051
Vancouver
Świtlik W, Wyżewski Z, Gregorczyk-Zboroch K, Gietler M, Pudlarz A, Szewińska J, et al. Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17051
BibTeX
@article{witlik2024,
author = {Świtlik, Weronika and Wyżewski, Zbigniew and Gregorczyk-Zboroch, Karolina and Gietler, Marta and Pudlarz, Agnieszka and Szewińska, Joanna and Orzechowski, Sławomir and Jakieła, Sławomir and Szemraj, Janusz},
title = {Deciphering the Role of miR-30a-5p and DLGAP1 Gene in Non-small Cell Lung Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17051}
}
EUVIMED